Methods for the detection of adverse drug reactions in hospitalized children: a systematic review

References

• Khalil H, Huang C. Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res. 2020;20(1):5.
   PubMed Web of Science ®Google Scholar
• Adverse Drug RM. Reactions in children: pediatric pharmacy and drug safety. J Pediatr Pharmacol Ther JPPT Off J PPAG. 2019;24:4–9.
   Google Scholar
• Elzagallaai AA, Greff M, Rieder MJ. Adverse drug reactions in children: the double-edged sword of therapeutics. Clin Pharmacol Ther. 2017;101(6):725–735.
   PubMed Web of Science ®Google Scholar
• Lo Giudice I, Mocciaro E, Giardina C, et al. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study. BMC Pharmacol Toxicol [Internet]. 2019 [cited 2021 Feb 1];20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486973/.
   Google Scholar
• Cliff-Eribo KO, Sammons H, Choonara I. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Expert Opin Drug Saf. 2016;15(10):1321–1328.
   PubMed Web of Science ®Google Scholar
• Khan LM. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay–a systematic review. Eur J Clin Pharmacol. 2013;69:1985–1996.
   PubMed Web of Science ®Google Scholar
• Sharma PK, Misra AK, Gupta N, et al. Pediatric pharmacovigilance in an institute of national importance: journey has just begun. Indian J Pharmacol. 2017;49:390–395.
   PubMed Web of Science ®Google Scholar
• Zed PJ. Adverse drug events in children: how big is the problem? Drug Metab Lett. 2015;9:109–110.
   PubMedGoogle Scholar
• Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol. 2010;70:481–491.
   PubMed Web of Science ®Google Scholar
• Smyth RMD, Gargon E, Kirkham J, et al. Adverse drug reactions in children—a systematic review. PLoS One. 2012 [cited 2021 Mar 24];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293884/
   Web of Science ®Google Scholar
• Organization WH The importance of pharmacovigilance [Internet]. World Health Organization; 2002 [cited 2021 Mar 24]. Available from: https://apps.who.int/iris/handle/10665/42493.
   Google Scholar
• Harry M, Lebel D, Comtois A, et al. Détection et codification des effets indésirables médicamenteux dans un centre hospitalier universitaire mère-enfant. Arch Pédiatrie. 2017;24(12):1179–1187.
   PubMed Web of Science ®Google Scholar
• Brvar M, Fokter N, Bunc M, et al. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol. 2009;9(1):8.
   PubMedGoogle Scholar
• Reumerman M, Tichelaar J, Piersma B, et al. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235–1248.
   PubMed Web of Science ®Google Scholar
• Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother. 2005;39(7–8):1169–1174.
   PubMed Web of Science ®Google Scholar
• Miguel A, Azevedo LF, Lopes F, et al. Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting. Pharmacoepidemiol Drug Saf. 2013;22(1):98–102.
   PubMed Web of Science ®Google Scholar
• Long AL, Horvath MM, Cozart H, et al. Tailoring adverse drug event surveillance to the paediatric inpatient. Qual Saf Health Care. 2010;19(5):e40.
   PubMedGoogle Scholar
• Black C, Tagiyeva-Milne N, Helms P, et al. Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review. Br J Clin Pharmacol. 2015;80(4):844–854.
   PubMed Web of Science ®Google Scholar
• MacLeod SM, Greff M, Knoppert DC, et al. An international asset map of clinicians, educators, and researchers pursuing better medicine use in children: initial findings. Clin Pharmacol Ther. 2017;101(2):274–280.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Wood G Guidance for Industry and FDA staff pediatric expertise for advisory panels. management [internet]. US Food and Drug Administration.; 2003. [cited 2020 Nov 20]. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm082188.pdf
   Google Scholar
• Van Den Anker J, Reed MD, Allegaert K, et al. Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol. 2018;58(Suppl 10):S10–S25.
   PubMed Web of Science ®Google Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–1167.
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H. Rayyan—a web and mobile app for systematic reviews | systematic reviews | full Text. Syst Rev. 2016;5(1):10.
   PubMedGoogle Scholar
• Sahu RK, Yadav R, Prasad P, et al. Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. SpringerPlus [Internet]. 2014 [cited 2021 Mar 24];3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258196/
   PubMedGoogle Scholar
• Amin S, Shah S, Desai M, et al. An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital. Perspect Clin Res. 2018;9(2):70–75.
   PubMedGoogle Scholar
• Priyadharsini R, Surendiran A, Adithan C, et al. A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother. 2011;2(4):277–280.
   PubMedGoogle Scholar
• Sindhu AR, Sebastian M, Panicker P. A study on adverse drug reactions in hospitalized pediatric patients in a Tertiary Care Hospital. J Appl Pharm Sci. 2019;9:72–76.
   Google Scholar
• Suman A. Study of adverse drug effects of antiepileptic drugs used in pediatric patients in a tertiary care rural hospital – a Pharmacovigilance study. J Young Pharm. 2017;9(1):60–64.
   Web of Science ®Google Scholar
• Sundaran S, Abhijith P, Aleena A. Spontaneous adverse drug reaction reporting in a tertiary care hospital in calicut | asian journal of pharmaceutical and clinical research. Asian J Pharm Clin Res. 2018;11(8):3.
   Google Scholar
• Velraj M. A prospective observational study on pattern of adverse drug reaction to antibiotics commonly prescribed in the hospitalized pediatric patients. Asian J Pharm Clin Res. 2018;11(4):118-120.
   Google Scholar
• Ithnin M, Rani MDM, Latif ZA, et al. Incidence of adverse drug reactions in a paediatric ward of a Malaysian hospital: a prospective observational study. Trop J Pharm Res. 2018;17(7):1423–1431.
   Web of Science ®Google Scholar
• Kirkendall ES, Kloppenborg E, Papp J, et al. Measuring adverse events and levels of harm in pediatric inpatients with the Global Trigger Tool. Pediatrics. 2012;130(5):e1206–1214.
   PubMed Web of Science ®Google Scholar
• Morales-Ríos O, Cicero-Oneto C, García-Ruiz C, et al. Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017. PloS One. 2020;15(3):e0230576.
   PubMed Web of Science ®Google Scholar
• Gallagher RM, Mason JR, Bird KA, et al. Adverse drug reactions causing admission to a paediatric hospital. PLoS One. 2012 [cited 2021 Mar 24];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514275/
   Web of Science ®Google Scholar
• Haffner S, Von Laue N, Wirth S, et al. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values. Drug Saf. 2005;28(5):453–464.
   PubMed Web of Science ®Google Scholar
• Neubert A, Dormann H, Weiss J, et al. Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol. 2006;62(11):959–965.
   PubMed Web of Science ®Google Scholar
• Fabretti SC, Brassica SC, Cianciarullo MA. Rastreadores para a busca ativa de eventos adversos a medicamentos em recém-nascidos. Cad Saúde Pública. 2018;34(9):12–17.
   Web of Science ®Google Scholar
• De Las Salas R, Díaz-Agudelo D, Burgos-Flórez FJ, et al. Adverse drug reactions in hospitalized Colombian children. Colomb Medica Cali Colomb. 2016;47:142–147.
   PubMed Web of Science ®Google Scholar
• Mouton JP, Fortuin-de Smidt MC, Jobanputra N, et al. Serious adverse drug reactions at two children’s hospitals in South Africa. BMC Pediatr. 2020;20(1):3.
   PubMed Web of Science ®Google Scholar
• Oshikoya K, Njokanma F, Chukwura HA, et al. Adverse drug reactions in Nigerian Children. Paediatr Perinat Drug Ther. 2007;8(2):81–88.
   Google Scholar
• Jiao F, Shamsi BH, Yan X, et al. Clinical analysis and study of 844 children with adverse drug reactions in China. Biomed Res [Internet]. 2018 [cited 2021 Mar 24];29. Available from: https://www.alliedacademies.org/abstract/clinical-analysis-and-study-of-844-children-with-adverse-drug-reactions-in-china-10052.html
   Google Scholar
• Andrade PHS, Lobo IMF, Da Silva WB. Risk factors for adverse drug reactions in pediatric inpatients: a cohort study. PloS One. 2017;12(8):e0182327.
   PubMed Web of Science ®Google Scholar
• Ferrajolo C, Capuano A, Trifirò G, et al. Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001-2012. Expert Opin Drug Saf. 2014;13(Suppl 1):S9–20.
   PubMed Web of Science ®Google Scholar
• MacLeod SM. Improving medicine use for children: a global imperative. Clin Pharmacol Ther. 2017;101(6):715–717.
   PubMed Web of Science ®Google Scholar
• Ampadu HH, Hoekman J, De Bruin ML, et al. Adverse drug reaction reporting in africa and a comparison of individual case safety report characteristics between africa and the rest of the world: analyses of spontaneous reports in vigibase®. Drug Saf. 2016;39(4):335–345.
   PubMed Web of Science ®Google Scholar
• Barry A, Olsson S, Minzi O, et al. Comparative assessment of the national pharmacovigilance systems in East Africa: ethiopia, Kenya, Rwanda and Tanzania. Drug Saf. 2020;43(9):339–350.
   PubMed Web of Science ®Google Scholar
• Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol. 2015;8(4):449–460.
   PubMed Web of Science ®Google Scholar
• Potts J, Genov G, Segec A, et al. Improving the safety of medicines in the European Union: from signals to action. Clin Pharmacol Ther. 2020;107(3):521–529.
   PubMed Web of Science ®Google Scholar
• Aagaard L, Strandell J, Melskens L, et al. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBaseTM. Drug Saf. 2012;35(12):1171–1182.
   PubMed Web of Science ®Google Scholar
• Blake KV, Zaccaria C, Domergue F, et al. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Paediatr Drugs. 2014;16(4):309–319.
   PubMed Web of Science ®Google Scholar
• Vázquez-Alvarez AO, Brennan-Bourdon LM, Rincón-Sánchez AR, et al. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients. BMC Pharmacol Toxicol. 2017;18:79.
   PubMed Web of Science ®Google Scholar
• Ramos SF, Gad SJ, Pereira AM, et al. Facilitators and strategies to implement clinical pharmacy services in a metropolis in Northeast Brazil: a qualitative approach. BMC Health Serv Res. 2018;18(1):632.
   PubMed Web of Science ®Google Scholar
• Allegaert K, Van Den Anker JN. Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol. 2015;80(4):788–795.
   PubMed Web of Science ®Google Scholar
• Naessens JM, Campbell CR, Huddleston JM, et al. A comparison of hospital adverse events identified by three widely used detection methods. Int J Qual Health Care J Int Soc Qual Health Care. 2009;21(4):301–307.
   PubMed Web of Science ®Google Scholar
• Rojas-Velandia C, Ruiz-Garzón J, J-c M-A, et al. Characterization of adverse drug reactions causing admission to an intensive care unit. Br J Clin Pharmacol. 2017;83(5):1134–1140.
   PubMed Web of Science ®Google Scholar
• Wolfe D, Yazdi F, Kanji S, et al. Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: a systematic review of systematic reviews. PLoS One. 2018 [cited 2021 Feb 1];13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181371/
   Web of Science ®Google Scholar
• Thiesen S, Conroy EJ, Bellis JR, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11(1):237.
   PubMed Web of Science ®Google Scholar
• Forster AJ, Worthington JR, Hawken S, et al. Using prospective clinical surveillance to identify adverse events in hospital. BMJ Qual Saf. 2011;20:756–763.
   PubMed Web of Science ®Google Scholar
• Forster AJ, Huang A, Lee TC, et al. Study of a multisite prospective adverse event surveillance system. BMJ Qual Saf. 2020;29:277–285.
   PubMed Web of Science ®Google Scholar
• Backman C, Forster AJ, Vanderloo S. Barriers and success factors to the implementation of a multi-site prospective adverse event surveillance system. Int J Qual Health Care J Int Soc Qual Health Care. 2014;26:418–425.
   PubMed Web of Science ®Google Scholar
• Forster AJ, Jennings A, Chow C, et al. A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc JAMIA. 2012;19:31–38.
   PubMed Web of Science ®Google Scholar
• Smith JC, Chen Q, Denny JC, et al. Evaluation of a novel system to enhance clinicians’ recognition of preadmission adverse drug reactions. Appl Clin Inform. 2018;9:313–325.
   PubMed Web of Science ®Google Scholar
• Cederholm S, Hill G, Asiimwe A, et al. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. Drug Saf. 2015;38:87–100.
   PubMed Web of Science ®Google Scholar
• Carli D, Fahrni G, Bonnabry P, et al. Quality of decision support in computerized provider order entry: systematic literature review. JMIR Med Inform. 2018;6:e3.
   PubMed Web of Science ®Google Scholar
• Ibáñez-Garcia S, Rodriguez-Gonzalez C, Escudero-Vilaplana V, et al. Development and evaluation of a clinical decision support system to improve medication safety. Appl Clin Inform. 2019;10:513–520.
   PubMed Web of Science ®Google Scholar
• Unbeck M, Lindemalm S, Nydert P, et al. Validation of triggers and development of a pediatric trigger tool to identify adverse events. BMC Health Serv Res. 2014;14:655.
   PubMed Web of Science ®Google Scholar
• Stockwell DC, Landrigan CP, Schuster MA, et al. Using a pediatric trigger tool to estimate total harm burden hospital-acquired conditions represent. Pediatr Qual Saf. 2018;3:e081.
   PubMedGoogle Scholar
• Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19–31.
   PubMed Web of Science ®Google Scholar
• Park K, Soukavong M, Kim J, et al. Signal detection of imipenem compared to other drugs from korea adverse event reporting system database. Yonsei Med J. 2017;58:564–569.
   PubMed Web of Science ®Google Scholar
• Terblanche A, Meyer JC, Godman B, et al. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis. Hosp Pract. 2017 [1995];45:238–245.
   PubMedGoogle Scholar
• Pal SN, Duncombe C, Falzon D, et al. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36:75–81.
   PubMed Web of Science ®Google Scholar
• Fang H, Lin X, Zhang J, et al. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacol Toxicol [Internet]. 2017 [cited 2021 Mar 24];18. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485713/
   Google Scholar
• Hadi MA, Neoh CF, Zin RM, et al. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017;6:91–98.
   PubMed Web of Science ®Google Scholar
• Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8:13–20.
   PubMed Web of Science ®Google Scholar
• Alwhaibi M, Alhindi G, Alshamrani M, et al. Pharmacovigilance in healthcare education: students’ knowledge, attitude and perception: a cross-sectional study in Saudi Arabia. BMC Med Educ. 2020;20:210.
   PubMed Web of Science ®Google Scholar
• Alwhaibi M, Al Aloola NA. Healthcare students’ knowledge, attitude and perception of pharmacovigilance: a systematic review. PLoS One. 2020 [cited 2021 Mar 24];15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239457/
   Web of Science ®Google Scholar
• Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2018;26:453–461.
   PubMed Web of Science ®Google Scholar
• Morales Ríos O, Jasso Gutiérrez L, Talavera JO, et al. A comprehensive intervention for adverse drug reactions identification and reporting in a pediatric emergency department. Int J Clin Pharm. 2016;38:80–87.
   PubMed Web of Science ®Google Scholar
• Khalili M, Mesgarpour B, Sharifi H, et al. Interventions to improve adverse drug reaction reporting: a scoping review. Pharmacoepidemiol Drug Saf. 2020;29:965–992.
   PubMed Web of Science ®Google Scholar
• Varallo FR, Planeta CS, Mastroianni P DC. Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics. 2017;72:51–57.
   PubMed Web of Science ®Google Scholar
• Bhagavathula AS, Elnour AA, Jamshed SQ, et al. Health professionals’ knowledge, attitudes and practices about Pharmacovigilance in India: a systematic review and meta-analysis. PloS One. 2016;11:e0152221.
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.
   PubMed Web of Science ®Google Scholar
• Belhekar MN, Taur SR, Munshi RP. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions. Indian J Pharmacol. 2014;46:117–120.
   PubMed Web of Science ®Google Scholar
• Behera SK, Das S, Xavier AS, et al. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018;40:903–910.
   PubMed Web of Science ®Google Scholar
• Khan LM, Al-Harthi SE, Osman A-M-M, et al. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J SPJ. 2016;24:485–493.
   PubMed Web of Science ®Google Scholar
• Du W, Lehr VT, Lieh-Lai M, et al. An algorithm to detect adverse drug reactions in the neonatal intensive care unit. J Clin Pharmacol. 2013;53:87–95.
   PubMed Web of Science ®Google Scholar
• Roberts EK, Hawcutt DB, Turner MA. Prospective identification and causality evaluation of suspected adverse drug reactions in neonates. Br J Clin Pharmacol. 2020;87:1541–1546.
   PubMed Web of Science ®Google Scholar